Erratum to: Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study)

被引：0
|
作者：
Pere Gascón
Matti Aapro
Heinz Ludwig
Carsten Bokemeyer
Mario Boccadoro
Matthew Turner
Kris Denhaerynck
Karen MacDonald
Ivo Abraham
机构：
[1] University of Barcelona,Division of Medical Oncology, Department of Hematology
[2] Clinique de Genolier,Oncology, Hospital Clínic de Barcelona
[3] Wilhelminenspital,Institut Multidisciplinaire d’Oncologie
[4] Universitaetsklinikum Hamburg Eppendorf,Medizinische Abteilung I–Onkologie und Haematologie
[5] Universitaria S. Giovanni Battista di Torino,Dipartimento di Oncologia e Ematologia, Azienda Ospedaliero
[6] Sandoz Biopharmaceuticals,Center for Health Outcomes and PharmacoEconomic Research
[7] University of Arizona,undefined
来源：
Supportive Care in Cancer | 2016年 / 24卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：927 / 927
相关论文
共 50 条
  • [1] Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study)
    Gascon, Pere
    Aapro, Matti
    Ludwig, Heinz
    Bokemeyer, Carsten
    Boccadoro, Mario
    Turner, Matthew
    Denhaerynck, Kris
    MacDonald, Karen
    Abraham, Ivo
    SUPPORTIVE CARE IN CANCER, 2016, 24 (02) : 911 - 925
  • [2] Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study)
    Pere Gascón
    Matti Aapro
    Heinz Ludwig
    Carsten Bokemeyer
    Mario Boccadoro
    Matthew Turner
    Kris Denhaerynck
    Karen MacDonald
    Ivo Abraham
    Supportive Care in Cancer, 2016, 24 : 911 - 925
  • [3] MONITOR-GCSF DLBCL subanalysis: Treatment patterns/outcomes with biosimilar filgrastim for chemotherapy-induced/febrile neutropenia prophylaxis
    Gascon, Pere
    Krendyukov, Andriy
    Hoebel, Nadja
    Aapro, Matti
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 100 (03) : 241 - 246
  • [4] Predictive modeling of the outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (MONITOR-GCSF study)
    Aapro, M.
    Ludwig, H.
    Bokemeyer, C.
    Gascon, P.
    Boccadoro, M.
    Denhaerynck, K.
    Krendyukov, A.
    Gorray, M.
    MacDonald, K.
    Abraham, I.
    ANNALS OF ONCOLOGY, 2016, 27 (11) : 2039 - 2045
  • [5] Prophylaxis of chemotherapy-induced febrile neutropenia with biosimilar filgrastim: Description of patients, treatment patterns and outcomes in the MONITOR-GCSF Study in Germany
    Bokemeyer, C.
    Ottillinger, B.
    Bulenda, D.
    Turner, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 161 - 161
  • [6] Prophylaxis of chemotherapy-induced febrile neutropenia with biosimilar filgrastim: Description of patients, treatment patterns and outcomes in the MONITOR-GCSF study in the breast cancer cohort
    Gascon, Pere
    Aapro, Matti
    Ludwig, Heinz
    Boccadoro, Mario
    Bokemeyer, Carsten
    Turner, Matthew
    Muenzberg, Michael
    Abraham, Ivo
    Denhaerynck, Kris
    MacDonald, Karen
    CANCER RESEARCH, 2015, 75
  • [7] Treatment patterns and outcomes in patients with breast cancer receiving biosimilar filgrastim for prophylaxis of chemotherapy-induced/febrile neutropenia: Results from the MONITOR-GCSF study
    Aapro, M.
    Krendyukov, A.
    Krivtsova, N.
    Gascon, P.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S53 - S53
  • [8] Chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim in solid tumours versus haematological malignancies: Patterns, outcomes and determinants (MONITOR-GCSF study)
    Aapro, M.
    Bokemeyer, C.
    Boccadoro, M.
    Gascon, P.
    Denhaerynck, K.
    Krendyukov, A.
    Abraham, I.
    Macdonald, K.
    Ludwig, H.
    ANNALS OF ONCOLOGY, 2017, 28
  • [9] Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF study
    Ludwig, Heinz
    Bokemeyer, Carsten
    Aapro, Matti
    Boccadoro, Mario
    Gascon, Pere
    Denhaerynck, Kris
    Krendyukov, Andriy
    Abraham, Ivo
    MacDonald, Karen
    FUTURE ONCOLOGY, 2019, 15 (08) : 897 - 908
  • [10] Predictive modeling of the outcomes of chemotherapy-induced (febrile) neutropenia (CIN/FN) prophylaxis with biosimilar filgrastim and development of an outcomes risk calculator (MONITOR-GCSF study)
    Aapro, M.
    Ludwig, H.
    Bokemeyer, C.
    Gascon, P.
    Boccadoro, M.
    Turner, M.
    Denhaerynck, K.
    MacDonald, K.
    Abraham, I.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S236 - S236
12345